Lataa...

Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens

Background. The optimal retreatment strategy for chronic hepatitis C virus (HCV) patients who fail directly-acting antiviral agent (DAA)-based treatment is unknown. In this study, we assessed the efficacy and safety of ledipasvir (LDV) and sofosbuvir (SOF) for 12 weeks in HCV genotype-1 (GT-1) patie...

Täydet tiedot

Tallennettuna:

Bibliografiset tiedot
Julkaisussa:	Clin Infect Dis
Päätekijät:	Wilson, Eleanor M., Kattakuzhy, Sarah, Sidharthan, Sreetha, Sims, Zayani, Tang, Lydia, McLaughlin, Mary, Price, Angie, Nelson, Amy, Silk, Rachel, Gross, Chloe, Akoth, Elizabeth, Mo, Hongmei, Subramanian, G. Mani, Pang, Phillip S., McHutchison, John G., Osinusi, Anu, Masur, Henry, Kohli, Anita, Kottilil, Shyam
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Oxford University Press 2016
Aiheet:	Articles and Commentaries
Linkit:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4706633/ https://ncbi.nlm.nih.gov/pubmed/26521268 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ874
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!

Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens

Samankaltaisia teoksia